Moderna COVID-19 Vaccine

On December 18, 2020, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).(3 days ago) FDA's career scientists and physicians in the Center for Biologics Evaluation and Research made a determination that the emergency use authorization request met the criteria for issuing an EUA.(Aug 12, 2021) I was not able to find if the inventors of the Vaccine vaccine record as if they were vaccinated or not.